98 related articles for article (PubMed ID: 8297103)
1. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue.
Gribbestad IS; Fjösne HE; Haugen OA; Nilsen G; Krane J; Petersen SB; Kvinnsland S
Anticancer Res; 1993; 13(6A):1973-80. PubMed ID: 8297103
[TBL] [Abstract][Full Text] [Related]
2. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy.
Gribbestad IS; Sitter B; Lundgren S; Krane J; Axelson D
Anticancer Res; 1999; 19(3A):1737-46. PubMed ID: 10470108
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
4. High-resolution magic angle spinning MRS of breast cancer tissue.
Sitter B; Sonnewald U; Spraul M; Fjösne HE; Gribbestad IS
NMR Biomed; 2002 Aug; 15(5):327-37. PubMed ID: 12203224
[TBL] [Abstract][Full Text] [Related]
5. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy.
Cheng LL; Chang IW; Smith BL; Gonzalez RG
J Magn Reson; 1998 Nov; 135(1):194-202. PubMed ID: 9799694
[TBL] [Abstract][Full Text] [Related]
6. Investigation of breast cancer using two-dimensional MRS.
Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
[TBL] [Abstract][Full Text] [Related]
7. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue.
Gribbestad IS; Petersen SB; Fjøsne HE; Kvinnsland S; Krane J
NMR Biomed; 1994 Jun; 7(4):181-94. PubMed ID: 7946996
[TBL] [Abstract][Full Text] [Related]
8. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
9. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps.
Beckonert O; Monnerjahn J; Bonk U; Leibfritz D
NMR Biomed; 2003 Feb; 16(1):1-11. PubMed ID: 12577292
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of TRAF4 protein in breast carcinoma].
Dai WB; Zheng YW; Mi XY; Liu N; Lin H; Yan J
Ai Zheng; 2007 Oct; 26(10):1095-8. PubMed ID: 17927880
[TBL] [Abstract][Full Text] [Related]
13. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
Soriano Z; Pardee JD
Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
[TBL] [Abstract][Full Text] [Related]
14. [In vitro NMR spectroscopy of healthy, pathologically changed and carcinomatous breast tissue samples correlated with histological findings].
Speckter H; Blümich B; Just M; Trömel U; Mitze M; Thelen M
Rofo; 1994 Aug; 161(2):147-53. PubMed ID: 8054548
[TBL] [Abstract][Full Text] [Related]
15. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
16. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
17. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.
Yang Y; Li C; Nie X; Feng X; Chen W; Yue Y; Tang H; Deng F
J Proteome Res; 2007 Jul; 6(7):2605-14. PubMed ID: 17564425
[TBL] [Abstract][Full Text] [Related]
18. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.
Sóñora C; Mazal D; Berois N; Buisine MP; Ubillos L; Varangot M; Barrios E; Carzoglio J; Aubert JP; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):289-99. PubMed ID: 16148312
[TBL] [Abstract][Full Text] [Related]
20. Quantification of amounts and (13)C content of metabolites in brain tissue using high- resolution magic angle spinning (13)C NMR spectroscopy.
Risa O; Melø TM; Sonnewald U
NMR Biomed; 2009 Apr; 22(3):266-71. PubMed ID: 19012315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
